The Huberman Lab
The Huberman Lab

Essentials: Using Hypnosis to Enhance Mental & Physical Health & Performance | Dr. David Spiegel

In this Huberman Lab Essentials episode, my guest is Dr. David Spiegel, MD, the Associate Chair of Psychiatry & Behavioral Sciences, Director of the Center on Stress and Health, and Director of the Center for Integrative Medicine at Stanford University School of Medicine. We discuss the science

Featured Speakers

Scicomm Media Host

Topics Discussed

Episode Summary

Executive Summary: This episode features Dr. David Spiegel explaining clinical hypnosis as a state of highly focused attention that can enhance control over mind and body. It contrasts stage hypnosis with therapeutic self-hypnosis, outlines the neuroscience involving the dorsal anterior cingulate, dorsolateral prefrontal cortex, insula, and posterior cingulate cortex, and presents clinical applications for stress, sleep, pain, phobias, and PTSD. The discussion emphasizes hypnotizability as a measurable trait, the importance of voluntary confrontation for therapeutic change, and introduces a self-hypnosis app named Reverie.

Main Topics: What is Clinical Hypnosis? (Priority: 5/5): Defined as a state of highly focused attention akin to being absorbed in a movie, where critical judgment is suspended and cognitive flexibility increases. Contrasted with stage hypnosis, which can make people feel out of control. Neuroscience of Hypnosis (Priority: 5/5): Key brain changes during hypnosis: decreased activity in the dorsal anterior cingulate cortex (conflict detector), increased functional connectivity between DLPFC and insula (mind-body control), and inverse connectivity between DLPFC and posterior cingulate cortex (reducing self-referential thought). Clinical Applications and Evidence (Priority: 5/5): Used for stress reduction, insomnia, pain management, phobias, and PTSD. Randomized trial evidence shows hypnosis improves PTSD treatment outcomes and reduces procedure time and anxiety in children. Detailed case of an attempted rape survivor illustrates restructuring traumatic memory. Hypnotizability and the Eye-Roll Test (Priority: 3/5): Hypnotizability is the capacity to enter hypnosis, normally distributed in the population. The Hypnotic Induction Profile includes the eye-roll test—looking up while closing eyelids—which predicts hypnotizability. About two-thirds of adults are hypnotizable. Mind-Body Control and Self-Hypnosis (Priority: 4/5): Hypnosis enables conscious control over autonomic functions. Example: subjects increased gastric acid secretion by 87% imagining food and decreased it by 40% relaxing. Self-hypnosis is taught to give patients ongoing control and can be reinforced via apps like Reverie. State-Dependent Memory and Trauma (Priority: 4/5): Hypnosis facilitates accessing traumatic memories because it induces a state similar to dissociation during trauma. This allows reprocessing and restructuring the meaning of the experience, turning passive suffering into active coping.

Key Arguments: Hypnosis enhances control over mind and body, contrary to the misconception that it involves loss of control. The key to therapeutic change is voluntary confrontation of trauma or phobia combined with restructuring one's emotional response. Hypnosis is a tool for cognitive flexibility—allowing people to shift mental sets, reduce self-judgment, and adopt new perspectives. State-dependent memory means hypnosis can help access traumatic memories by matching the dissociative state in which they were encoded. Adding hypnosis to standard PTSD treatment improves outcomes, as shown by a randomized trial in Israel. Breathing, particularly slow exhalation, can be used during hypnosis induction to enhance parasympathetic activity. Children can be effectively hypnotized and benefit from it in medical procedures, as supported by a randomized trial in Pediatrics. People with OCD tend to be less hypnotizable due to over-control of thought, making hypnosis less effective for them. The brain's dorsolateral prefrontal cortex can control bodily functions (e.g., gastric acid secretion) through the insula during hypnosis.

Data Points: Gastric acid secretion increase: 87% - Subjects hypnotized and instructed to imagine eating favorite foods showed an 87% increase in gastric acid secretion. Gastric acid secretion decrease: 40% - Same subjects later told to relax and think of anything but food showed a 40% decrease in gastric acid. Gastric acid reduction despite pentagastrin injection: 19% - Even when injected with pentagastrin (which triggers gastric acid release), hypnotized subjects had a 19% reduction in acid. Hypnotizability prevalence: Two-thirds of adults - About two-thirds of adults are hypnotizable; 15% are extremely hypnotizable. Procedure time reduction for children: 17 minutes - Children undergoing voiding cystourethrograms with hypnosis had procedures shortened by an average of 17 minutes.

Pivotal Quotes: "Hypnosis is a state of highly focused attention. It's something like looking through the telephoto lens of a camera in consciousness. What you see, you see with great detail, but devoid of context." — Dr. David Spiegel: Opening definition of hypnosis in the episode. "The issue is control, and hypnosis, which has this terrible reputation of taking away control, is actually a superb way of enhancing your control over mind and body." — Dr. David Spiegel: Addressing the common misconception about hypnosis and control. "You need to reconfront a traumatic situation before you can modulate your associations to it and then figure out how you can approach that problem or how you did approach that problem from a different point of view." — Dr. David Spiegel: Explaining the therapeutic mechanism for trauma in hypnosis.

Implications: Clinical hypnosis offers a rapid, evidence-based tool for stress, pain, sleep, and trauma, with self-administration via apps making it accessible. Its integration into mainstream therapy could reduce reliance on medication, but requires trained clinicians to ensure safety. Future research should strengthen neural evidence and expand applications.

🔓 Sign Up for Unlimited Episode Search

About The Huberman Lab

The Huberman Lab podcast is hosted by Andrew Huberman, Ph.D., a neuroscientist and tenured professor in the department of neurobiology, and by courtesy, psychiatry and behavioral sciences at Stanford School of Medicine. The podcast discusses neuroscience and science-based tools, including how our brain and its connections with the organs of our body control our perceptions, our behaviors, and our health, as well as existing and emerging tools for measuring and changing how our nervous system works. Huberman has made numerous significant contributions to the fields of brain development, brain function, and neural plasticity, which is the ability of our nervous system to rewire and learn new behaviors, skills, and cognitive functioning. He is a McKnight Foundation and Pew Foundation Fellow and was awarded the Cogan Award, given to the scientist making the most significant discoveries in the study of vision, in 2017. Work from the Huberman Laboratory at Stanford School of Medicine has been published in top journals, including Nature, Science, and Cell, and has been featured in TIME, BBC, Scientific American, Discover, and other top media outlets. In 2021, Dr. Huberman launched the Huberman Lab podcast. The podcast is frequently ranked in the top 10 of all podcasts globally and is often ranked #1 in the categories of Science, Education, and Health & Fitness.

View all episodes from The Huberman Lab